What serious adverse reactions happened during this study? The table below shows the serious adverse reactions that happened during the study. The numbers in parentheses are the number of participants who had an adverse reaction.

Serious adverse reactions:
- Dapagliflozin: Narrowing of the arteries in the arms and legs - 0.6% (1), High blood sugar - 0.6% (1), Liver not working properly - 0.0% (0), Sudden kidney damage - 0.0% (0)
- Placebo: Narrowing of the arteries in the arms and legs - 0.0% (0), High blood sugar - 0.0% (0), Liver not working properly - 0.6% (1), Sudden kidney damage - 0.6% (1)

None of the participants died due to serious adverse reactions.

What adverse reactions happened during this study? The most common adverse reaction was low blood pressure. The table below shows the adverse reactions that happened in 2 or more participants during the study. There were other adverse reactions, but these happened in only 1 participant each. Some participants may have had more than 1 adverse reaction. The numbers in parentheses are the number of participants who had an adverse reaction.

Most common adverse reactions:
- Dapagliflozin: Low blood pressure - 1.9% (3), Cough - 1.3% (2), Painful urination - 1.3% (2), Kidney function getting worse - 0.6% (1)
- Placebo: Low blood pressure - 1.3% (2), Cough - 0.0% (0), Painful urination - 0.0% (0), Kidney function getting worse - 0.6% (1)